Author/Creator: Fish, Douglas N - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Fish, Douglas N

1. Antibiotic Susceptibilities and Appropriateness of Initial Drug Selection for Community-Acquired Urinary Tract Infections (UTI) Caused by Extended-Spectrum Β-Lactamase (ESBL)-Producing Pathogens. (4th October 2017)

Authors:: Lee, Stephen; Fish, Douglas N; Barber, Gerard; Barron, Michelle
Journal:: Open forum infectious diseases
Issue:: Volume 4(2017)Supplement 1
Page Start:: S347
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Case–control Study Evaluating Risk Factors and Treatment Outcomes for Community-Acquired Urinary Tract Infections (UTI) Caused by Extended-Spectrum Β-Lactamase (ESBL)-Producing Pathogens. (4th October 2017)

Authors:: Lee, Stephen; Fish, Douglas N; Barber, Gerard; Barron, Michelle
Journal:: Open forum infectious diseases
Issue:: Volume 4(2017)Supplement 1
Page Start:: S345
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting. (29th January 2020)

Authors:: Derington, Catherine G; Benavides, Nancy; Delate, Thomas; Fish, Douglas N
Journal:: Open forum infectious diseases
Issue:: Volume 7:Number 2(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events. (February 2015)

Authors:: MacLaren, Robert; Kassel, Lynn E; Kiser, Tyree H; Fish, Douglas N
Journal:: Expert opinion on drug safety
Issue:: Volume 14:Number 2(2015:Mar.)
Page Start:: 269
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success. (23rd May 2022)

Authors:: Morrisette, Taylor; Molina, Kyle C; Da Silva, Beatriz; Mueller, Scott W; Damioli, Laura; Krsak, Martin; Miller, Matthew A; Fish, Douglas N
Journal:: Open forum infectious diseases
Issue:: Volume 9:Number 6(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗